Status:
COMPLETED
Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)
Lead Sponsor:
Pharmacosmos A/S
Collaborating Sponsors:
BioStata
Conditions:
Iron Deficiency Anemia
Eligibility:
All Genders
Brief Summary
The purpose of this study is to monitor and quality assure the efficacy and safety of Monofer® in a broad patient population when Monofer® is used according to the Monofer® label (SPC) in current prac...
Detailed Description
The total duration of the study is approximately 21 months, which includes a 6 months enrolment period. The number of patient visits depends on the number of Monofer® treatment courses needed during t...
Eligibility Criteria
Inclusion
- Patients with iron deficiency anemia treated on the doctor's discretion with Monofer® as standard treatment according to current practice
Exclusion
- None
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
391 Patients enrolled
Trial Details
Trial ID
NCT01900197
Start Date
August 1 2013
End Date
November 1 2015
Last Update
March 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg, Denmark